Article Information
History
- May 28, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Akshita Gupta1,2,*,
- Elda Righi3,*,†,
- Angelina Konnova1,2,
- Concetta Sciammarella3,
- Gianluca Spiteri4,
- Vincent Van Averbeke1,
- Matilda Berkell1,2,
- An Hotterbeekx1,2,
- Assunta Sartor5,
- Massimo Mirandola3,6,
- Surbhi Malhotra-Kumar2,
- Anna Maria Azzini3,
- Diletta Pezzani3,
- Maria Grazia Lourdes Monaco4,
- Guido Vanham7,
- Stefano Porru4,
- Evelina Tacconelli3,† and
- Samir Kumar-Singh1,2,#,†
- 1Molecular Pathology Group, Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
- 2Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
- 3Infectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, Verona, Italy
- 4Occupational Medicine Unit, Department of Diagnostics and Public Health, University of Verona, Verona, Italy
- 5Microbiology Unit, Udine University Hospital, Udine, Italy
- 6School of Health Sciences, University of Brighton, Brighton, United Kingdom
- 7Global Health Institute, University of Antwerp, Belgium
- ↵#Correspondence
: samir.kumarsingh{at}uantwerpen.be
Posted May 28, 2024.
IL-2-mediated CD4 T-cell activation correlates highly with effective serological and T-cell responses to SARS-CoV-2 vaccination in people living with HIV (PLWH)
